{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001867066","name":"Journey Medical Corp","summary":"Journey Medical Corporation is a commercial-stage pharmaceutical company focused on selling and marketing FDA-approved prescription drugs for dermatological conditions. Its portfolio includes eight products targeting rosacea, acne, primary axillary hyperhidrosis, and fungal skin infections, marketed under brands such as Emrosi, Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Exelderm, and Luxamend. The company acquires product rights through licensing or ownership, funds R&D, and commercializes via its field sales organization. It is a controlled subsidiary of Fortress Biotech, Inc.","people":[],"products":[{"name":"Emrosi","type":"service","description":"40mg minocycline hydrochloride extended release capsule for inflammatory lesions of rosacea in adults; FDA approved November 2024."},{"name":"Qbrexza","type":"service","description":"Glycopyrronium 2.4% medicated cloth towelette for primary axillary hyperhidrosis in patients nine years and older."},{"name":"Accutane","type":"service","description":"Oral isotretinoin capsules for treatment of severe recalcitrant nodular acne."},{"name":"Amzeeq","type":"service","description":"4% minocycline topical foam for inflammatory lesions of moderate-to-severe acne vulgaris in patients nine years and older."},{"name":"Zilxi","type":"service","description":"1.5% minocycline topical foam for inflammatory lesions of rosacea in adults."},{"name":"Targadox","type":"service","description":"Oral doxycycline hyclate 50mg tablets as adjunctive therapy for severe acne."},{"name":"Exelderm","type":"service","description":"Broad-spectrum antifungal cream and solution for topical use."},{"name":"Luxamend","type":"service","description":"Water-based emulsion for moist healing environment for superficial wounds and skin conditions."}],"partnerships":[{"partner_name":"Dr. Reddys Laboratories, Ltd.","partnership_type":"development","description":"Collaborated on development of Emrosi (DFD-29), the 40mg minocycline hydrochloride extended release capsule for rosacea.","start_date":null},{"partner_name":"Fortress Biotech, Inc.","partnership_type":"strategic","description":"Journey Medical is a controlled subsidiary of Fortress Biotech, Inc., its parent company.","start_date":null}],"affiliations":[],"origin":{"leaf":"74321047b1e30d8ba69598d2c330240b6f5b43681726e847aca3d961d2ec78f7","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"3ac8e2a0740da43867b504681d4a0ea1558452d02d6da18b18a5dc42c69a4ea9","parent":"e032170fcac43b8ecf16949a38f5dbca6224d2069b5256631d9382b9b0ab3497","source":"0001104659-26-034629","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":393,"hourly_limit":500,"remaining":107,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}